Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $2,668 | 11 | 61.2% |
| Food and Beverage | $1,695 | 35 | 38.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $1,367 | 8 | $0 (2023) |
| Relievant Medsystems, Inc. | $1,157 | 9 | $0 (2023) |
| Nevro Corp. | $1,136 | 7 | $0 (2022) |
| Biohaven Pharmaceutical Holding Company Ltd. | $156.83 | 5 | $0 (2022) |
| Radius Health, Inc. | $152.68 | 2 | $0 (2023) |
| Collegium Pharmaceutical, Inc. | $126.46 | 4 | $0 (2022) |
| PFIZER INC. | $70.83 | 4 | $0 (2023) |
| ABBVIE INC. | $61.98 | 2 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $53.85 | 1 | $0 (2022) |
| Averitas Pharma Inc. | $46.72 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $99.68 | 4 | Averitas Pharma Inc. ($46.72) |
| 2023 | $2,665 | 24 | Abbott Laboratories ($1,367) |
| 2022 | $1,598 | 18 | Nevro Corp. ($1,136) |
All Payment Transactions
46 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/18/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: ETONOGESTREL | ||||||
| 07/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $33.88 | General |
| Category: NEUROSCIENCE | ||||||
| 03/21/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $26.92 | General |
| Category: PAIN MANAGEMENT | ||||||
| 01/29/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/11/2023 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $28.10 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: PAIN | ||||||
| 10/05/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: PAIN | ||||||
| 09/07/2023 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Pain Management | ||||||
| 08/14/2023 | Relievant Medsystems, Inc. | Intracept (Device), Intracept, Intracept | Food and Beverage | Cash or cash equivalent | $81.00 | General |
| Category: Pain | ||||||
| 07/28/2023 | Relievant Medsystems, Inc. | Intracept (Device), Intracept, Intracept | Travel and Lodging | Cash or cash equivalent | $26.67 | General |
| Category: Pain | ||||||
| 07/24/2023 | Relievant Medsystems, Inc. | Intracept (Device), Intracept, Intracept | Travel and Lodging | Cash or cash equivalent | $107.44 | General |
| Category: Pain | ||||||
| 07/24/2023 | Relievant Medsystems, Inc. | Intracept (Device), Intracept, Intracept | Travel and Lodging | Cash or cash equivalent | $71.51 | General |
| Category: Pain | ||||||
| 07/24/2023 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $27.68 | General |
| Category: Endocrinology | ||||||
| 07/15/2023 | Relievant Medsystems, Inc. | Intracept (Device), Intracept, Intracept | Food and Beverage | Cash or cash equivalent | $184.80 | General |
| Category: Pain | ||||||
| 07/12/2023 | Relievant Medsystems, Inc. | Intracept (Device), Intracept, Intracept | Travel and Lodging | Cash or cash equivalent | $225.04 | General |
| Category: Pain | ||||||
| 07/12/2023 | Relievant Medsystems, Inc. | Intracept (Device), Intracept, Intracept | Food and Beverage | Cash or cash equivalent | $148.31 | General |
| Category: Pain | ||||||
| 06/23/2023 | Relievant Medsystems, Inc. | Intracept (Device), Intracept, Intracept | Food and Beverage | Cash or cash equivalent | $22.55 | General |
| Category: Pain | ||||||
| 06/19/2023 | Relievant Medsystems, Inc. | Intracept (Device), Intracept, Intracept | Travel and Lodging | Cash or cash equivalent | $289.45 | General |
| Category: Pain | ||||||
| 06/08/2023 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 05/24/2023 | Abbott Laboratories | PROCLAIM (Device) | Travel and Lodging | In-kind items and services | $252.14 | General |
| Category: Neuromodulation | ||||||
| 05/24/2023 | Abbott Laboratories | PROCLAIM (Device) | Travel and Lodging | In-kind items and services | $9.07 | General |
| Category: Neuromodulation | ||||||
| 03/14/2023 | Abbott Laboratories | PROCLAIM (Device) | Travel and Lodging | In-kind items and services | $703.84 | General |
| Category: Neuromodulation | ||||||
| 03/14/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $90.83 | General |
| Category: Neuromodulation | ||||||
| 03/14/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $38.20 | General |
| Category: Neuromodulation | ||||||
| 03/05/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $32.66 | General |
| Category: Neuromodulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 944 | 1,937 | $712,509 | $148,309 |
| 2022 | 6 | 537 | 806 | $274,809 | $70,026 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 359 | 918 | $261,420 | $68,025 | 26.0% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 71 | 145 | $116,000 | $22,252 | 19.2% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 152 | 328 | $164,000 | $19,975 | 12.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 112 | 112 | $45,136 | $10,247 | 22.7% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 22 | 29 | $23,200 | $7,017 | 30.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 88 | 112 | $21,205 | $6,127 | 28.9% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 47 | 54 | $43,200 | $5,855 | 13.6% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 22 | 25 | $20,000 | $4,869 | 24.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 14 | $5,768 | $1,635 | 28.4% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 14 | 16 | $4,400 | $1,235 | 28.1% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 11 | 12 | $2,040 | $475.80 | 23.3% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 11 | 12 | $5,100 | $456.48 | 9.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 24 | 160 | $1,040 | $138.67 | 13.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 252 | 452 | $113,000 | $37,063 | 32.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 78 | 78 | $31,434 | $8,313 | 26.4% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 40 | 54 | $43,200 | $8,288 | 19.2% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 83 | 116 | $58,000 | $7,020 | 12.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 69 | 89 | $15,575 | $5,223 | 33.5% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 15 | 17 | $13,600 | $4,119 | 30.3% |
About Jonathan Farrell
Jonathan Farrell is a Physician Assistant healthcare provider based in Hood River, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/11/2020. The National Provider Identifier (NPI) number assigned to this provider is 1144831520.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jonathan Farrell has received a total of $4,363 in payments from pharmaceutical and medical device companies, with $99.68 received in 2024. These payments were reported across 46 transactions from 12 companies. The most common payment nature is "Travel and Lodging" ($2,668).
As a Medicare-enrolled provider, Farrell has provided services to 1,481 Medicare beneficiaries, totaling 2,743 services with total Medicare billing of $218,335. Data is available for 2 years (2022–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Hood River, OR
- Active Since 08/11/2020
- Last Updated 05/18/2022
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1144831520
Products in Payments
- PROCLAIM (Device) $1,367
- Intracept (Device) $1,157
- Senza (Device) $1,059
- NURTEC ODT (Drug) $193.96
- Tymlos (Biological) $125.00
- Omnia (Device) $76.84
- UBRELVY (Drug) $61.98
- BELBUCA (Drug) $54.41
- ELYXYB - celecoxib (Drug) $54.41
- RELISTOR (Drug) $53.85
- QUTENZA (Drug) $46.72
- PAXLOVID (Drug) $33.70
- Tymlos (Drug) $27.68
- NEXPLANON (Drug) $19.08
- XTAMPZA (Drug) $17.64
- Nalu Neurostimulation System (Device) $14.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Hood River
Ms. Holly Tumelson, Pa-C, PA-C
Physician Assistant — Payments: $1,416
Melissa Arndt, P.a, P.A
Physician Assistant — Payments: $576.84
Laura Russell, Pa-C, PA-C
Physician Assistant — Payments: $10.74
Jenny Harris, P.a, P.A
Physician Assistant
Ms. Stacey Campbell, Pa-C, PA-C
Physician Assistant
Mr. Robert Fiske, Pa-C, PA-C
Physician Assistant